220 related articles for article (PubMed ID: 33997007)
1. Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
Aalami AH; Abdeahad H; Mesgari M; Sathyapalan T; Sahebkar A
Biomed Res Int; 2021; 2021():5557309. PubMed ID: 33997007
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer.
Shabayek MI; Sayed OM; Attaia HA; Awida HA; Abozeed H
Pathol Oncol Res; 2014 Oct; 20(4):859-66. PubMed ID: 24696417
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis.
Xie Q; Huang Z; Zhu Z; Zheng X; Liu J; Zhang M; Zhang Y
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):38-44. PubMed ID: 27363065
[TBL] [Abstract][Full Text] [Related]
7. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: a systematic review with meta-analysis.
Yang X; Huang H; Zeng Z; Zhao L; Hu P; He D; Tang X; Zeng Z
Clin Biochem; 2013 Oct; 46(15):1377-82. PubMed ID: 23735602
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
Wang Z; Wang X; Zhang D; Yu Y; Cai L; Zhang C
Tumour Biol; 2017 Jun; 39(6):1010428317709990. PubMed ID: 28639914
[TBL] [Abstract][Full Text] [Related]
10. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
11. ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis.
He H; Han C; Hao L; Zang G
Oncol Lett; 2016 Jul; 12(1):83-88. PubMed ID: 27347104
[TBL] [Abstract][Full Text] [Related]
12. Detection of Circulating Cell-Free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-Analysis.
Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
Curr Med Chem; 2023 Jun; ():. PubMed ID: 37349993
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis.
Cui X; Jing X; Long C; Yi Q; Tian J; Zhu J
Oncotarget; 2017 May; 8(21):35222-35233. PubMed ID: 28415640
[TBL] [Abstract][Full Text] [Related]
14. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
Xia Y; Liu YL; Yang KH; Chen W
Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
Liang Z; Xin R; Yu Y; Wang R; Wang C; Liu X
World J Urol; 2018 Sep; 36(9):1373-1381. PubMed ID: 29610963
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
Mi Y; Zhao Y; Shi F; Zhang M; Wang C; Liu X
Asia Pac J Clin Oncol; 2019 Apr; 15(2):e11-e19. PubMed ID: 29931834
[TBL] [Abstract][Full Text] [Related]
18. CCL18 in a multiplex urine-based assay for the detection of bladder cancer.
Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S
PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
Shi HB; Yu JX; Yu JX; Feng Z; Zhang C; Li GY; Zhao RN; Yang XB
World J Surg Oncol; 2017 Aug; 15(1):147. PubMed ID: 28774300
[TBL] [Abstract][Full Text] [Related]
20. Novel urinary biomarkers for the detection of bladder cancer: A systematic review.
Tan WS; Tan WP; Tan MY; Khetrapal P; Dong L; deWinter P; Feber A; Kelly JD
Cancer Treat Rev; 2018 Sep; 69():39-52. PubMed ID: 29902678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
